Source: Health Products Regulatory Authority (ZA) Revision Year: 2023 Publisher: RANBAXY PHARMACEUTICALS (PTY) LTD., 14 LAUTRE ROAD, STORMILL EXT.1, ROODEPOORT 1724, SOUTH AFRICA
RHINETON (4 mg tablet).
Pharmaceutical Form |
---|
Tablet. Yellow, round, biconvex tablet, with a diameter of 7,20 mm, and a score on the one side. |
Each RHINETON tablet contains Chlorpheniramine maleate 4mg.
Contains sugar: Lactose monohydrate 103,645 mg per tablet.
Active Ingredient | Description | |
---|---|---|
Chlorphenamine |
Chlorphenamine is a potent antihistamine (H1-antagonist). Antihistamines diminish or abolish the actions of histamine in the body by competitive reversible blockade of histamine H1-receptor sites on tissues. Chlorphenamine also has anticholinergic activity. |
List of Excipients |
---|
Lactose monohydrate |
Containers of 30, 100 and 1000 tablets.
Patient ready packs of different pack sizes.
RANBAXY PHARMACEUTICALS (PTY) LTD., 14 LAUTRE ROAD, STORMILL EXT.1, ROODEPOORT 1724, SOUTH AFRICA
36/5.7.1/0166
24 October 2003
Drug | Countries | |
---|---|---|
RHINETON | South Africa |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.